ARCT-154

ARCT-154
Deskripsi vaksin
TargetSARS-CoV-2
Jenis vaksinmRNA
Data klinis
Nama lainVBC-COV19-154
Rute
pemberian		Intraotot

ARCT-154, juga dikenal sebagai VBC-COV19-154 di Vietnam, adalah sebuah kandidat vaksin Covid-19 yang dikembangkan oleh Arcturus Therapeutics.[1][2] Untuk pengembangannya, Arcturus berkolaborasi dengan Vinbiocare, sebuah perusahaan Vietnam, untuk mendukung pengujian klinik dan produksi.

Referensi

  1. ^ "Vingroup collaborates with Arcturus Therapeutics to establish a manufacturing facility in Vietnam for Arcturus' mRNA Covid-19 vaccine". Yahoo! Finance. August 2, 2021.
  2. ^ Giang NK (2 August 2021). "Arcturus Allows Vietnam's Vingroup to Make Covid Vaccines". Bloomberg.
Scholia memiliki profil tentang ARCT-154 (Q107860980).

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.
Kembali kehalaman sebelumnya